5alpha Reductase: Drug Class Monograph

4 source-based articles maintained by the HealthRX.com Editorial Team.

4articles

3topic areas covered

Jan 28, 2025latest review

5alpha Reductase: Drug Class Monograph library

Showing 4 of 4 clinical reviews.

Clinical ReviewsJan 28, 2025

5-α Reductase Inhibitors Adverse-Event Management Protocols

A prescriber-level guide to recognizing, grading, and managing adverse events from finasteride and dutasteride, with dosing tables, monitoring schedules, and evidence-based mitigation strategies.

Clinical ReviewsMay 27, 2026

5-α Reductase Inhibitors Class Overview Monograph

Clinical monograph covering the 5-α reductase inhibitor drug class, including finasteride and dutasteride. Mechanism, pharmacokinetics, landmark trials, dosing, adverse effects, and prescribing considerations for BPH and androgenetic alopecia.

Reviews & OutcomesJan 28, 2025

5-α Reductase Inhibitors Drug-Drug Interaction Table: Full Class Review for Prescribers

Complete DDI table for finasteride and dutasteride, with mechanism-based interaction data, prescribing guidance, and clinical pearls at MD/PharmD level.

QuestionsJan 28, 2025

5-α Reductase Inhibitors: How to Select the Right Agent Within the Class

A prescriber-level guide to finasteride vs. Dutasteride: mechanism, isoenzyme coverage, approved indications, dosing, side-effect profiles, and evidence-based selection criteria for BPH and androgenetic alopecia.